Model
Edge
Regeneron Pharmaceuticals, Inc.
0001683607
Filing type
144
Filing date
Jan 6, 2026
Updated
Jan 7, 2026 ยท 10:03 AM
Copy reference
Filing
144
Notice of Proposed Sale of Securities